Morristown, NJ, United States of America

Chengmin Zhang


 

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 47(Granted Patents)


Location History:

  • Morristown, NJ (US) (2009 - 2014)
  • Kendall Park, NJ (US) (2010 - 2014)

Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Mind of Chengmin Zhang

Introduction

Chengmin Zhang is a notable inventor based in Morristown, NJ, USA, recognized for his remarkable contributions to the field of pharmaceutical innovations. With a portfolio of 7 patents, Chengmin has made significant strides in developing compounds that are aimed at treating various diseases and disorders, reflecting his commitment to enhancing healthcare solutions.

Latest Patents

Among his latest creations, Chengmin has developed 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds. These compounds, along with their compositions, offer methods for treating, preventing, and managing a range of diseases and disorders. Another notable patent involves Tryptophan hydroxylase inhibitors, which include compounds of formulae I and II. These are also aimed at addressing serotonin-mediated diseases and disorders effectively.

Career Highlights

Chengmin Zhang currently holds a significant position at Lexicon Pharmaceuticals, Inc., a company dedicated to innovative therapies for serious and challenging diseases. His work illustrates his dedication to improving therapeutic outcomes through inventive solutions and rigorous research.

Collaborations

Throughout his career, Chengmin has collaborated with esteemed colleagues such as Arokiasamy Devasagayaraj and Haihong Jin. These partnerships have fostered a supportive environment for discussing ideas and advancing their research towards novel pharmaceutical inventions.

Conclusion

Chengmin Zhang's contributions to the field of pharmaceuticals through his innovative patents represent a blend of creativity and scientific rigor. His ongoing work at Lexicon Pharmaceuticals and his collaborations with other talented researchers further underscore his commitment to addressing critical health challenges through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…